Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedAug 17, 2025
DataAggregated Company Financials
Companies9
  • 7D4.3%
  • 3M5.5%
  • 1Y-0.9%
  • YTD7.4%

Over the last 7 days, the Pharma industry has risen 4.3%, driven by gains from Novartis of 5.8%. Meanwhile, BioVersys actually underperformed within the industry, shrinking 9.7% in the last week. Overall in the last year, the industry is flat. Looking forward, earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 17 Aug 2025CHF 469.4bCHF 120.9bCHF 21.1b31.1x22.3x3.9x
Tue, 15 Jul 2025CHF 450.4bCHF 117.3bCHF 18.9b24.8x23.8x3.8x
Thu, 12 Jun 2025CHF 457.2bCHF 118.9bCHF 19.2b25.9x23.8x3.8x
Sat, 10 May 2025CHF 429.1bCHF 119.5bCHF 19.3b24.8x22.2x3.6x
Mon, 07 Apr 2025CHF 421.7bCHF 120.3bCHF 19.0b25.2x22.2x3.5x
Wed, 05 Mar 2025CHF 487.8bCHF 121.8bCHF 19.0b23.9x25.7x4x
Fri, 31 Jan 2025CHF 462.4bCHF 119.6bCHF 21.4b19.5x21.6x3.9x
Sun, 29 Dec 2024CHF 425.4bCHF 119.2bCHF 21.4b17.9x19.9x3.6x
Tue, 26 Nov 2024CHF 431.1bCHF 118.2bCHF 21.2b18.3x20.4x3.6x
Thu, 24 Oct 2024CHF 463.0bCHF 115.9bCHF 19.5b21.8x23.8x4x
Sat, 21 Sep 2024CHF 456.3bCHF 114.9bCHF 19.3b21.8x23.6x4x
Mon, 19 Aug 2024CHF 467.7bCHF 115.9bCHF 19.5b22.1x24x4x
Wed, 17 Jul 2024CHF 447.9bCHF 116.1bCHF 19.7b34.4x22.7x3.9x
Fri, 14 Jun 2024CHF 426.0bCHF 116.1bCHF 19.7b34x21.6x3.7x
Sun, 12 May 2024CHF 405.5bCHF 113.2bCHF 19.9b40.9x20.4x3.6x
Tue, 09 Apr 2024CHF 396.4bCHF 112.1bCHF 19.4b37.3x20.4x3.5x
Thu, 07 Mar 2024CHF 392.0bCHF 110.5bCHF 19.7b24.6x19.9x3.5x
Sat, 03 Feb 2024CHF 399.2bCHF 114.1bCHF 19.2b30.3x20.8x3.5x
Mon, 01 Jan 2024CHF 394.8bCHF 118.7bCHF 18.6b25.4x21.3x3.3x
Wed, 29 Nov 2023CHF 387.5bCHF 120.9bCHF 18.9b24.5x20.5x3.2x
Fri, 27 Oct 2023CHF 387.7bCHF 122.4bCHF 19.1b23.9x20.3x3.2x
Sun, 24 Sep 2023CHF 402.8bCHF 113.2bCHF 18.1b45.4x22.2x3.6x
Tue, 22 Aug 2023CHF 401.9bCHF 111.8bCHF 17.9b47.2x22.4x3.6x
Thu, 20 Jul 2023CHF 414.3bCHF 114.0bCHF 19.2b36.9x21.6x3.6x
Sat, 17 Jun 2023CHF 428.0bCHF 115.0bCHF 18.9b38.1x22.7x3.7x
Mon, 15 May 2023CHF 436.6bCHF 115.3bCHF 18.9b40.5x23.1x3.8x
Wed, 12 Apr 2023CHF 429.8bCHF 115.2bCHF 18.9b42.2x22.8x3.7x
Fri, 10 Mar 2023CHF 384.7bCHF 116.8bCHF 19.1b26.2x20.1x3.3x
Sun, 05 Feb 2023CHF 429.0bCHF 117.9bCHF 21.3b28.7x20.2x3.6x
Tue, 03 Jan 2023CHF 431.6bCHF 117.1bCHF 34.6b22.5x12.5x3.7x
Thu, 01 Dec 2022CHF 446.1bCHF 118.4bCHF 35.2b23x12.7x3.8x
Sat, 29 Oct 2022CHF 458.0bCHF 120.9bCHF 36.2b22.3x12.7x3.8x
Mon, 26 Sep 2022CHF 428.8bCHF 120.6bCHF 37.0b20.2x11.6x3.6x
Wed, 24 Aug 2022CHF 447.7bCHF 119.6bCHF 36.6b21.2x12.2x3.7x
Price to Earnings Ratio

12.2x


Total Market Cap: CHF 447.7bTotal Earnings: CHF 36.6bTotal Revenue: CHF 119.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 20.5x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 20.5x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.03%
Healthcare3.48%
Pharma4.33%
Pharma4.33%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 99.495.8%
+CHF 10.5b		0.02%PE17.5x
ROG Roche HoldingCHF 256.003.9%
+CHF 8.2b		-9.0%PE23.1x
GALD Galderma GroupCHF 132.001.5%
+CHF 451.1m		65.1%PE102.8x
SDZ Sandoz GroupCHF 47.941.4%
+CHF 280.0m		28.7%PE112.8x
DESN Dottikon ES HoldingCHF 299.500.3%
+CHF 13.8m		16.3%PE39.2x

Latest News

NWRN
CHF 7.01
Newron Pharmaceuticals
7D
-6.2%
1Y
-7.8%
DESN
CHF 299.50
Dottikon ES Holding
7D
0.3%
1Y
16.3%

Does Dottikon ES Holding (VTX:DESN) Have A Healthy Balance Sheet?

Aug 13
Does Dottikon ES Holding (VTX:DESN) Have A Healthy Balance Sheet?
SDZ
CHF 47.94
Sandoz Group
7D
1.4%
1Y
28.7%
NOVN
CHF 99.49
Novartis
7D
5.8%
1Y
0.02%
ROG
CHF 256.00
Roche Holding
7D
3.9%
1Y
-9.0%
ADXN
CHF 0.054
Addex Therapeutics
7D
-3.9%
1Y
4.2%
COPN
CHF 55.50
Cosmo Pharmaceuticals
7D
-0.9%
1Y
-29.4%
GALD
CHF 132.00
Galderma Group
7D
1.5%
1Y
65.1%
BIOV
CHF 26.20
BioVersys
7D
-9.7%
1Y
n/a
CURN
CHF 11.85
Curatis Holding
7D
-0.4%
1Y
99.5%